Effects of L-threo-3,4-dihydroxyphenylserine on orthostatic hypotension in hemodialysis patients

American Journal of Nephrology

Volumn 22, Issue 4, 2002, Pages 338-346

  Iida, Nobutoshi ^a   Koshikawa, Syozo ^b   Akizawa, Tadao ^c   Tsubakihara, Yoshiharu ^d   Marumo, Fumiaki ^e   Akiba, Takashi ^f   Kawaguchi, Yoshindo ^g   Imada, Akio ^h   Yamazaki, Chikao ⁱ   Suzuki, Masashi ^j  

^a YODOGAWA CHRISTIAN HOSPITAL   (Japan)

^b SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

^c WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^d OSAKA GENERAL MEDICAL CENTER   (Japan)

^e TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^f TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^g JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁱ Masuko Memorial Hospital   (Japan)

^j Shinrakuen Hospital   (Japan)

more..

Author keywords

Autonomic nerve dysfunction; Hemodialysis; L Threo DOPS; Orthostatic hypotension

Indexed keywords

PLACEBO; THREO 3,4 DIHYDROXYPHENYLSERINE;

ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE CALCULATION; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; FEMALE; HEMODIALYSIS; HUMAN; HYPOTENSION; INCIDENCE; MALAISE; MALE; NORADRENALIN BLOOD LEVEL; ORTHOSTATIC HYPERTENSION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STANDING; TIME; VERTIGO;

AUTONOMIC NERVOUS SYSTEM DISEASES; CARDIOVASCULAR AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DROXIDOPA; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYPOTENSION, ORTHOSTATIC; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NOREPINEPHRINE; RENAL DIALYSIS; STATISTICS;

EID: 18544389122     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000065224     Document Type: Article

References (17)

1. Studies on the activity of L-threo-3,4-dihydroxyphenylserine (L-DOPS) as a catecholamine precursor in the brain: Comparison with that of L-DOPA
2. Effect of infused L-threo-3,4-dihydroxyphenylserine on adrenergic activity in patients with familial amyloid polyneuropathy
3. Clinical effect of L-threo-3,4-dihydroxyphenylserine on orthostatic hypotension in Shy-Drager syndrome and its related diseases
4. Clinical effects of L-threo-3,4-dihydroxyphenylserine in Parkinson's disease and parkinsonian syndrome
5. Treatment of dialysis-induced hypotension with L-threo-3,4-dihydroxyphenylserine
6. Clinical effects of L-threo-3,4-dihydroxyphenylserine on orthostatic hypotension in hemodialysis patients
7. Pharmacology of amezinium, a novel antihypotensive drug. IV. Biochemical investigations of the mechanism of action
8. Pharmacodynamic actions of midodrine, a new alpha-adrenergic stimulating agent, and its main metabolite ST-1059
9. Amelioration of hemodialysis-associated hypotension by the use of cool dialysate
10. Evaluation of autonomic functions in regular hemodialysis patients: Pathogenesis and management of orthostatic hypotension
11. Norepinephrine clearance, chromogranin A and dopamine beta-hydroxylase in renal failure
12. Changes of plasma catecholamine concentration in dialysis induced hypotensive patients
13. A clinical study on the mechanism of hypotension during hemodialysis in patients with chronic renal failure as assessed by functions of the autonomic nervous system
14. Uremic autonomic dysfunction evaluated by pattern recognition analysis
15. Twenty-four-hour blood pressure variations and autonomic nervous system disorders in hemodialysis patients
16. Autonomic nervous system dysfunction and volume nonresponsive hypotension in hemodialysis patients
17. D,L-Threo-3,4-dihydroxyphenylserine restores sympathetic control and cures orthostatic hypotension in dopamine beta-hydroxylase deficiency